World s largest study of global climate related mortality links 5 million deaths a year to abnormal temperatures miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Advertisement
People have started to look at Professor Nancy Baxter strangely when she meets their attempt at a handshake with an elbow bump.
âThereâs a sense of âweâre back to normal, we donât deal with all this COVID stuffâ,â the clinical epidemiologist says.
Australians are in a âhoneymoonâ period as the absence of COVID-19 has allowed people to get up close.
Credit:Meredith OâShea
Australia hasnât seen a significant outbreak of coronavirus since spring last year. In fact, some communities never have, and with just 22 people hospitalised with COVID-19 around the nation, the most tangible sign of the disease is often a bottle of hand sanitiser at the door of the supermarket or cafe.
Saturday 1 May is Mesh Awareness Day, and the beginning of Mesh Awareness Month.
This is a time to acknowledge the many women whose lives and wellbeing have been impacted due to complications associated with pelvic mesh.
This year’s mesh awareness anniversary is also an opportunity to highlight the significant initiatives that have been undertaken to safeguard women from similar experiences.
A Senate Inquiry (2018) into pelvic mesh complications prompted important changes to the nation’s health system, including the establishment of a $2.3m Commonwealth-funded clinical registry. The Australasian Pelvic Floor Procedure Registry (APFPR), hosted by Monash University, is a national quality initiative that aims to register all women undergoing pelvic mesh procedures.
Date Time
Could treatment with a statin preserve brain function after COVID-19 infection?
A new clinical trial led by a UNSW Medicine & Health professor receives more than $2.3m in funding.
An innovative study to assess whether a commonly used cholesterol lowering medication can prevent brain complications from COVID-19 has received more than $2.3 million from the Medical Research Future Fund (MRFF).
The study is a collaboration between The George Institute for Global Health, UNSW Sydney, Monash University’s School of Public Health, University of Sydney and Sydney Local Health District. It is one of six clinical trials to begin in 2021 that have received grants totalling $10 million through the MRFF Clinical Trials Activity Initiative.
Two major grants offer support for international mother-baby iron supplements study
A Melbourne-led research consortium investigating the impact of iron treatments on maternal and newborn health in low-income countries has received two major grants from the Bill & Melinda Gates Foundation worth almost $US 9.6 million.
The funding, awarded in 2020, will support major clinical trials in Malawi, South Asia, Africa and Bangladesh, investigating whether intravenous iron treatment given to women in pregnancy improves the physical and psychological health of mothers, and the growth and brain development of their babies. The study will also address whether intravenous iron supplements impact mother-baby bonding and breastfeeding rates.